Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Current Taxes (2020 - 2025)

Universe Pharmaceuticals' Current Taxes history spans 6 years, with the latest figure at $640.8 million for Q3 2025.

  • For Q3 2025, Current Taxes fell 37.25% year-over-year to $640.8 million; the TTM value through Sep 2025 reached $640.8 million, down 37.25%, while the annual FY2025 figure was $640.8 million, 37.25% down from the prior year.
  • Current Taxes for Q3 2025 was $640.8 million at Universe Pharmaceuticals, down from $1.0 billion in the prior quarter.
  • Across five years, Current Taxes topped out at $1.0 billion in Q3 2024 and bottomed at $167350.0 in Q3 2022.
  • The 5-year median for Current Taxes is $1.5 million (2021), against an average of $332.8 million.
  • The largest annual shift saw Current Taxes plummeted 88.98% in 2022 before it surged 234784.92% in 2024.
  • A 5-year view of Current Taxes shows it stood at $1.5 million in 2021, then tumbled by 88.98% to $167350.0 in 2022, then surged by 159.79% to $434758.0 in 2023, then soared by 234784.92% to $1.0 billion in 2024, then tumbled by 37.25% to $640.8 million in 2025.
  • Per Business Quant, the three most recent readings for UPC's Current Taxes are $640.8 million (Q3 2025), $1.0 billion (Q3 2024), and $434758.0 (Q3 2023).